Access
Email Verification
Agenda 2024
TBC
0830 - 0930 REGISTRATION AND MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 RESERVED PRESENTATION
1010 - 1030 SPEED NETWORKING SESSION
- Exchange business cards and get connected in short one-to-one meetings
- Start the conversation to arrange a more formal meeting later on in the conference
- Share your professional background and discuss your biggest business issues – don't forget your business cards!
Conference Host
1030 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1130 PANEL DISCUSSION ON POINT-OF-CARE TESTING
1130 - 1200 RESERVED PRESENTATION
1200 - 1330 NETWORKING LUNCH & VISITING THE POINT-OF-CARE TESTING EXHIBITION
1330 - 1355 IMPROVING PATIENT ACCESS TO CARE: POINT-OF-CARE TESTING IN THE COMMUNITY PHARMACY
- Understanding the evolution and significance of POCT in pharmacies, especially for infectious diseases
- Analyzing challenges and exploring solutions for broader implementation of pharmacy-based testing
- Evaluating test features and usability for manufacturers, and supporting pharmacies in adopting POCT
Donald Klepser
University of Nebraska Medical Center
University of Nebraska Medical Center
1355 - 1400 Q&A SESSION ON POCT IN COMMUNITY PHARMACIES
1400 - 1430 RESERVED PRESENTATION
1430 - 1500 AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
1500 - 1525 POINT-OF-CARE TESTING IN SEXUAL HEALTH. A PARADIGM SHIFT IN PATIENT CARE
- Demonstrating key product features driving mass adoption and enhancing accessibility
- Sharing lessons learned from the national commercial rollout, focusing on best practices
- Illustrating how technical advances are improving patient outcomes and transforming care
Jeff Luber
Binx Health
Binx Health
1525 - 1530 Q&A SESSION ON POINT-OF-CARE TESTING IN SEXUAL HEALTH
1530 - 1600 RESERVED PRESENTATION
1600 - 1700 NETWORKING DRINKS RECEPTION
TBC
0900 - 0930 MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 RESERVED PRESENTATION
1010 - 1035 BRINGING LAB-QUALITY UNIVERSAL IMMUNOASSAY TO THE POINT OF CARE
- Addressing the challenge of achieving lab-quality immunoassays in a simplified, non-specific assay format
- Discussing two pathways to implement standard ELISA and multiplexed fluorescent immunoassays for point-of-care use
- Demonstrating how these methods can simplify instrumentation without sacrificing assay accuracy
Giles Sanders
TTP plc.
TTP plc.
1035 - 1040 Q&A SESSION ON LAB QUALITY IMMUNOASSAYS
1040 - 1100 MORNING COFFEE BREAK IN THE EXHIBIT AREA
1100 - 1125 HOW INNOVATION IS DRIVING THE EXPANSION IN LATERAL FLOW TECHNOLOGY USE
- Expanding the use of lateral flow testing into diverse fields over time
- Impacting the lateral flow technology landscape through COVID-19, fostering innovation
- Presenting current advancements and future trends by industry leaders like Abingdon Health
Mark Jones
Abingdon Health
Abingdon Health
1125 - 1130 Q&A SESSION ON DRIVING INNOVATION IN LATERAL FLOW TECHNOLOGY
1130 - 1155 FDA'S NEW QMSR AND ALIGNMENT WITH ISO 13485 – WHAT YOU NEED TO KNOW
- Describing the proposed Quality Management System Regulation (QMSR) and its 2026 implementation
- Outlining the key changes in QMSR, reasons for the revisions, and their impact on processes
- Clarifying how to prepare your company’s QMS for FDA inspections and key differences with ISO 13485
Vincent Cafiso
CREO
CREO
1155 - 1200 Q&A SESSION ON FDA'S NEW QMSR & ISO 13485 ALIGNMENT
1200 - 1215 FEEDBACK & RAFFLE DRAW
1215 - 1330 NETWORKING LUNCH
Key topics for 2024:
-
Global Healthcare Trends Driven by Point-of-Care Testing Technology
Explore state-of-the-art forecasts in point-of-care technology in the contemporary global healthcare landscape -
Enhanced diagnostic precision through advanced technology integration
Understand the integration of AI, IoT, and ML with POCT devices to revolutionize diagnostics -
Cutting-edge research in testing technologies to improve disease diagnosis
Familiarize with diverse disease testing methods enhanced by point-of-care diagnostics -
Development of lab-quality, multi-assay diagnostic tests on a single chip
Gain insights into Lab-on-a-Chip platforms translating POCT with microfluidics, nano biosensors and miniaturized devices -
Case studies on POCT in remote chronic disease management
Recognize next-generation smart POT's role in chronic healthcare through remote monitoring and antibiotic stewardship -
Navigating regulations and standardization of POCT through new channels
Learn from policymakers about regulatory approvals and reimbursement models for decentralized testing
Sponsorship Opportunities
Join us as a sponsor for this IQ International conference! Reach your target audience, limit competitor influence at the conference and become a keynote speaker, while sharing your company's solutions for this industry.
- Get registration discounts
- Enhance your brand awareness
- Additional marketing opportunities